These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8442150)

  • 61. Chance, choice and cause in cancer aetiology: individual and population perspectives.
    Davey Smith G; Relton CL; Brennan P
    Int J Epidemiol; 2016 Jun; 45(3):605-13. PubMed ID: 27565178
    [No Abstract]   [Full Text] [Related]  

  • 62. Histological predictors of outcome for cutaneous squamous cell carcinoma in renal transplant patients: A case-control study.
    Harvey NT; Palmer DJ; Tucker P; Chakera A; Foster R; Lim W; Trevithick RW; Wood BA
    JAAD Int; 2024 Jun; 15():51-58. PubMed ID: 38371661
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review.
    Tsang DA; Tam SYC; Oh CC
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980718
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cutaneous Squamous Cell Carcinoma Arising in Immunosuppressed Patients: A Systematic Review of Tumor Profiling Studies.
    Blue ED; Freeman SC; Lobl MB; Clarey DD; Fredrick RL; Wysong A; Whitley MJ
    JID Innov; 2022 Jul; 2(4):100126. PubMed ID: 35620703
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lower Genital Tract Precancer and Cancer in Hematopoietic Cell Transplant Survivors and the Role of HPV: A Systematic Review and Future Perspectives.
    Tanweer MS; Aljurf M; Savani BN; Iqbal PK; Hashmi S
    Clin Hematol Int; 2019 Sep; 1(3):142-153. PubMed ID: 34595424
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun Belt.
    Flukes S; Long S; Lohia S; Barker CA; Dunn LA; Cracchiolo J; Ganly I; Patel S; Cohen MA
    OTO Open; 2021; 5(1):2473974X20984720. PubMed ID: 33474523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vascularized Composite Allotransplantation: Medical Complications.
    Uluer MC; Brazio PS; Woodall JD; Nam AJ; Bartlett ST; Barth RN
    Curr Transplant Rep; 2016; 3(4):395-403. PubMed ID: 32288984
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin.
    van der Hem JGK; de Wreede LC; Brand A; Veelken H; Falkenburg JHF; Halkes CJM
    Haematologica; 2017 Oct; 102(10):e382-e383. PubMed ID: 28705902
    [No Abstract]   [Full Text] [Related]  

  • 69. Recurrent and metastatic squamous cell carcinoma in lung transplant recipient on voriconazole: Lessons learned.
    Zhang S; Neujahr DC; Zwald FO
    JAAD Case Rep; 2015 Nov; 1(6):S12-5. PubMed ID: 27051799
    [No Abstract]   [Full Text] [Related]  

  • 70. CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.
    Bottomley MJ; Harden PN; Wood KJ
    J Am Soc Nephrol; 2016 May; 27(5):1505-15. PubMed ID: 26563386
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
    Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
    Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Malignant neoplasms and kidney transplantation].
    Heynemann H; Hamza A; Wagner S; Hoda R; Schumann A; Fornara P
    Urologe A; 2009 Dec; 48(12):1443-51. PubMed ID: 19911154
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Malignancy in kidney transplant recipients.
    Kapoor A
    Drugs; 2008; 68 Suppl 1():11-9. PubMed ID: 18442297
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
    Gutierrez-Dalmau A; Campistol JM
    Drugs; 2007; 67(8):1167-98. PubMed ID: 17521218
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Posttransplantation malignancy in a patient presenting with weight loss and changed bowel habits: a case report.
    Schmitt R; Kettritz U; Luft FC; Kettritz R
    BMC Nephrol; 2006 May; 7():9. PubMed ID: 16674825
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Post-transplant malignancy: the role of immunosuppression.
    Penn I
    Drug Saf; 2000 Aug; 23(2):101-13. PubMed ID: 10945373
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of immunosuppression in lymphoma formation.
    Penn I
    Springer Semin Immunopathol; 1998; 20(3-4):343-55. PubMed ID: 9870250
    [No Abstract]   [Full Text] [Related]  

  • 78. Acute leukaemia following renal transplantation.
    Subar M; Gucalp R; Benstein J; Williams G; Wiernik PH
    Med Oncol; 1996 Mar; 13(1):9-13. PubMed ID: 8869934
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.
    Mazariegos GV; Ramos H; Shapiro R; Zeevi A; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):207-9. PubMed ID: 7878974
    [No Abstract]   [Full Text] [Related]  

  • 80. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.
    Sheil AG; Disney AP; Mathew TH; Amiss N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1383-4. PubMed ID: 8442150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.